Skip to content
Search

Latest Stories

GPhC appoints two new Chief officers

The pharmacy regulator has welcomed two new executive officers to achieve next steps in their ‘strategic’ plans

The General Pharmaceutical Council (GPhC) recently appointed a chief pharmacy officer and a chief enforcement officer on 26 October.


Roz Gittins will be joining as chief pharmacy officer and deputy registrar whereas Dionne Spence as chief enforcement officer and deputy registrar from 3 January.

The regulator confirmed that the new officers will “form the new executive structure of the GPhC”.

They will be working with the existing staff members Mark Voce, in his new role, is the chief strategy officer and deputy registrar and Jonathan Bennetts, will be the chief operating officer & deputy registrar.

It is stated that Gittins is to serve as "the most senior member of the profession," offering pharmacy leadership throughout the GPhC.

She will be tasked with "representing the pharmacy regulator authoritatively on professional issues in public."

In her role as the chief pharmacy officer, Gittins will provide comprehensive professional leadership within the GPhC, collaborating closely with the company's pharmacists and pharmacy technicians.

She said: "I’m looking forward to joining the GPhC team in the new year. As a registrant, I know how important it is for our regulator to connect more effectively with pharmacists and pharmacy technicians.

“I hope that this new role, alongside Dionne and other GPhC colleagues, offers a unique opportunity to influence progress, at an exciting and challenging time for the pharmacy professions."

Meanwhile, Dionne Spence will be overseeing and enhancing Fitness to Practise (FIT) processes and enforcement actions against registered pharmacies.

She will promote a consistent strategic and cultural approach to fitness to practice and pharmacy enforcement.

Talking about the company, Spence said: "I am delighted to be joining the GPhC, my second healthcare regulator, in this new and exciting role, and at such a critical time for the pharmacy professions.

“Coming in at the inception of this innovative approach to leadership, with a team so committed to streamlining our regulatory functions and improving the service provided to all users is incredibly exciting and will provide great benefit to the sector.”

More For You

Vaccine-preventable infections costing UK billions

Effective interventions are needed to prevent hospitalisations

Vaccine-preventable infections costing UK billions

Effective interventions are having a positive impact but more needs to be done to combat vaccine-preventable infections after data revealed today showed that it accounted for 20 per cent of hospital bed usage in the UK between 2023 to 2024 at a cost of almost £6 billion.

The return of social mixing, international travel and migration following the COVID-19 pandemic have contributed to the rise in both endemic disease and vaccine-preventable infections, according to the UK Health Security Agency's (UKHSA).

Keep ReadingShow less
Economic analysis of pharmacy finances will be published ‘imminently’ - Stephen Kinnock

Stephen Kinnock also confirms that the outcome of the negotiations with CPE will be announced "very soon."

parliamentlive.tv

NPA collective action “premature, unnecessary and detrimental to patients” - Stephen Kinnock

Health Minister Stephen Kinnock has announced that the government will be releasing the independent economic analysis of pharmacy finances “imminently.”

Responding to a question from shadow health minister Dr. Luke Evans in Parliament today (25), Kinnock criticised the National Pharmacy Association’s (NPA) collective action as “premature, unnecessary, and detrimental to community pharmacy patients.”

Keep ReadingShow less
NPA members are expected reduce opening hours and services from next week

NPA members are expected reduce opening hours and services from next week

Pic credit: iStock

NPA will become more “militant” as wait for pharmacy contract goes on

The government has been warned by the National Pharmacy Association (NPA) that community pharmacy will not back down from collective action and reducing opening hours from April 1st.

NPA board member, Ashley Cohen, told LBC today that the sector was in a "desperate situation" and that the representative body will do “whatever we can to protect our sector”.

Keep ReadingShow less
Community pharmacy needs investment and support to deliver neighbourhood health, says CCA chief

Community pharmacies see patients more than anyone else in the primary care system.

Getty Images

Community pharmacy key to neighbourhood health, but investment needed, says CCA chief

Community pharmacies can play a vital role in delivering a ‘neighbourhood health service’, provided they receive the necessary investment and support, according to Malcolm Harrison, chief executive of the Company Chemists’ Association (CCA).

Harrison's comments come in response to a new report from think tank Reform, titled Designing a Neighbourhood Health Service, which outlines key principles for achieving the government's vision of a more community-focused healthcare system.

Keep ReadingShow less
Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less